Cargando…

Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial

Objective To investigate the effect of vitamin A supplementation and BCG vaccination at birth in low birthweight neonates. Design Randomised, placebo controlled, two by two factorial trial. Setting Bissau, Guinea-Bissau. Participants 1717 low birthweight neonates born at the national hospital. Inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Benn, Christine Stabell, Fisker, Ane Bærent, Napirna, Bitiguida Mutna, Roth, Adam, Diness, Birgitte Rode, Lausch, Karen Rokkedal, Ravn, Henrik, Yazdanbakhsh, Maria, Rodrigues, Amabelia, Whittle, Hilton, Aaby, Peter
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835853/
https://www.ncbi.nlm.nih.gov/pubmed/20215360
http://dx.doi.org/10.1136/bmj.c1101
_version_ 1782178667538939904
author Benn, Christine Stabell
Fisker, Ane Bærent
Napirna, Bitiguida Mutna
Roth, Adam
Diness, Birgitte Rode
Lausch, Karen Rokkedal
Ravn, Henrik
Yazdanbakhsh, Maria
Rodrigues, Amabelia
Whittle, Hilton
Aaby, Peter
author_facet Benn, Christine Stabell
Fisker, Ane Bærent
Napirna, Bitiguida Mutna
Roth, Adam
Diness, Birgitte Rode
Lausch, Karen Rokkedal
Ravn, Henrik
Yazdanbakhsh, Maria
Rodrigues, Amabelia
Whittle, Hilton
Aaby, Peter
author_sort Benn, Christine Stabell
collection PubMed
description Objective To investigate the effect of vitamin A supplementation and BCG vaccination at birth in low birthweight neonates. Design Randomised, placebo controlled, two by two factorial trial. Setting Bissau, Guinea-Bissau. Participants 1717 low birthweight neonates born at the national hospital. Intervention Neonates who weighed less than 2.5 kg were randomly assigned to 25 000 IU vitamin A or placebo, as well as to early BCG vaccine or the usual late BCG vaccine, and were followed until age 12 months. Main outcome measure Mortality, calculated as mortality rate ratios (MRRs), after follow-up to 12 months of age for infants who received vitamin A supplementation compared with those who received placebo. Results No interaction was observed between vitamin A supplementation and BCG vaccine allocation (P=0.73). Vitamin A supplementation at birth was not significantly associated with mortality: the MRR of vitamin A supplementation compared with placebo, controlled for randomisation to “early BCG” versus “no early BCG” was 1.08 (95% CI 0.79 to 1.47). Stratification by sex revealed a significant interaction between vitamin A supplementation and sex (P=0.046), the MRR of vitamin A supplementation being 0.74 (95% CI 0.45 to 1.22) in boys and 1.42 (95% CI 0.94 to 2.15) in girls. When these data were combined with data from a complementary trial among normal birthweight neonates in Guinea-Bissau, the combined estimate of the effect of neonatal vitamin A supplementation on mortality was 1.08 (95% CI 0.87 to 1.33); 0.80 (95% CI 0.58 to 1.10) in boys and 1.41 (95% CI 1.04 to 1.90) in girls (P=0.01 for interaction between neonatal vitamin A and sex). Conclusions The combined results of this trial and the complementary trial among normal birthweight neonates have now shown that, overall, it would not be beneficial to implement a neonatal vitamin A supplementation policy in Guinea-Bissau. Worryingly, the trials show that vitamin A supplementation at birth can be harmful in girls. Previous studies and future trials should investigate the possibility that vitamin A supplementation has sex differential effects. Trial registration ClinicalTrials.gov NCT00168610.
format Text
id pubmed-2835853
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-28358532010-03-11 Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial Benn, Christine Stabell Fisker, Ane Bærent Napirna, Bitiguida Mutna Roth, Adam Diness, Birgitte Rode Lausch, Karen Rokkedal Ravn, Henrik Yazdanbakhsh, Maria Rodrigues, Amabelia Whittle, Hilton Aaby, Peter BMJ Research Objective To investigate the effect of vitamin A supplementation and BCG vaccination at birth in low birthweight neonates. Design Randomised, placebo controlled, two by two factorial trial. Setting Bissau, Guinea-Bissau. Participants 1717 low birthweight neonates born at the national hospital. Intervention Neonates who weighed less than 2.5 kg were randomly assigned to 25 000 IU vitamin A or placebo, as well as to early BCG vaccine or the usual late BCG vaccine, and were followed until age 12 months. Main outcome measure Mortality, calculated as mortality rate ratios (MRRs), after follow-up to 12 months of age for infants who received vitamin A supplementation compared with those who received placebo. Results No interaction was observed between vitamin A supplementation and BCG vaccine allocation (P=0.73). Vitamin A supplementation at birth was not significantly associated with mortality: the MRR of vitamin A supplementation compared with placebo, controlled for randomisation to “early BCG” versus “no early BCG” was 1.08 (95% CI 0.79 to 1.47). Stratification by sex revealed a significant interaction between vitamin A supplementation and sex (P=0.046), the MRR of vitamin A supplementation being 0.74 (95% CI 0.45 to 1.22) in boys and 1.42 (95% CI 0.94 to 2.15) in girls. When these data were combined with data from a complementary trial among normal birthweight neonates in Guinea-Bissau, the combined estimate of the effect of neonatal vitamin A supplementation on mortality was 1.08 (95% CI 0.87 to 1.33); 0.80 (95% CI 0.58 to 1.10) in boys and 1.41 (95% CI 1.04 to 1.90) in girls (P=0.01 for interaction between neonatal vitamin A and sex). Conclusions The combined results of this trial and the complementary trial among normal birthweight neonates have now shown that, overall, it would not be beneficial to implement a neonatal vitamin A supplementation policy in Guinea-Bissau. Worryingly, the trials show that vitamin A supplementation at birth can be harmful in girls. Previous studies and future trials should investigate the possibility that vitamin A supplementation has sex differential effects. Trial registration ClinicalTrials.gov NCT00168610. BMJ Publishing Group Ltd. 2010-03-09 /pmc/articles/PMC2835853/ /pubmed/20215360 http://dx.doi.org/10.1136/bmj.c1101 Text en © Benn et al 2010 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Research
Benn, Christine Stabell
Fisker, Ane Bærent
Napirna, Bitiguida Mutna
Roth, Adam
Diness, Birgitte Rode
Lausch, Karen Rokkedal
Ravn, Henrik
Yazdanbakhsh, Maria
Rodrigues, Amabelia
Whittle, Hilton
Aaby, Peter
Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial
title Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial
title_full Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial
title_fullStr Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial
title_full_unstemmed Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial
title_short Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial
title_sort vitamin a supplementation and bcg vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835853/
https://www.ncbi.nlm.nih.gov/pubmed/20215360
http://dx.doi.org/10.1136/bmj.c1101
work_keys_str_mv AT bennchristinestabell vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial
AT fiskeranebærent vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial
AT napirnabitiguidamutna vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial
AT rothadam vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial
AT dinessbirgitterode vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial
AT lauschkarenrokkedal vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial
AT ravnhenrik vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial
AT yazdanbakhshmaria vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial
AT rodriguesamabelia vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial
AT whittlehilton vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial
AT aabypeter vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial